Gastroparesis, and mostly found when on liraglutides (Saxenda),[1] though that hasn't stopped lawsuits against semaglutides.[2] There's some interest in GLP-1

Gastroparesis, and mostly found when on liraglutides (Saxenda),[1] though that hasn't stopped lawsuits against semaglutides.[2] There's some interest in GLP-1 receptor agonists as IBS _treatments_, specifically for pain relief in IBS-C and IBS-M, though it's way too early to talk about meaningfully.[3][4] 1: https://jamanetwork.com/journals/jama/fullarticle/2810542 https://jamanetwork.com/journals/jama/fullarticle/2810542 2: https://www.nbcnews.com/health/health-news/makers-ozempic-mounjaro-sued-stomach-paralysis-claims-rcna97819 https://www.nbcnews.com/health/health-news/makers-ozempic-mo... 3: https://pubmed.ncbi.nlm.nih.gov/35234561/ https://pubmed.ncbi.nlm.nih.gov/35234561/ 4: https://pubmed.ncbi.nlm.nih.gov/31602785/ https://pubmed.ncbi.nlm.nih.gov/31602785/